Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors
Clinical trial NCT01138033 · COMPLETED
Trial details
- NCT number
- NCT01138033
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-27
- Primary completion
- 2015-12-21
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.